A new model for funding medical science

Could crowd funding be a solution to the financing struggles of young biotech companies in the early stages of drug development? Clive Cookson talks to Andrew Ward about the benefits and pitfalls of this new model for financing medical science.

iTunes Stitcher audioBoom SoundCloud Overcast RSS

Copyright The Financial Times Limited 2017. All rights reserved. You may share using our article tools. Please don't copy articles from FT.com and redistribute by email or post to the web.